ArticleIntensive care research2023

Effect of the Timing of Amubarvimab/Romlusevimab (BRII-196/198) Administration on Progression to Severe Disease in Elderly Patients with COVID-19 Infection: A Retrospective Cohort Study.

Yonghao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.